Zantl, N <br/><br/>
Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.  [electronic resource] 

 -  Oncogene  Oct 2007 
 - 7038-48 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1210510  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>Antibiotics, Antineoplastic--pharmacology<br/>Apoptosis--physiology<br/>Apoptosis Regulatory Proteins--genetics<br/>Bcl-2-Like Protein 11<br/>Blotting, Western<br/>Carcinoma, Renal Cell--genetics<br/>Down-Regulation<br/>Doxorubicin--pharmacology<br/>Flow Cytometry<br/>Humans<br/>Immunoglobulin G--immunology<br/>Kidney Neoplasms--metabolism<br/>Membrane Proteins--genetics<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>RNA, Small Interfering--pharmacology<br/>Rabbits<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Protein p53--metabolism<br/>bcl-2-Associated X Protein--metabolism<br/>bcl-X Protein--metabolism